Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mario Romero
University of Texas Dallas, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
NerveSolutions, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NerveSolutions is commercializing nerve stimulation and neuromodulation devices, including devices used in delivery of pelvic floor muscle training. This project aims to evaluate the use of neuromodulation as a therapy for urinary incontinence. The project results could appear to benefit the financial interests of NerveSolutions.
Dr. Romero’s financial interest in NerveSolutions could significantly and directly affect the conduct of this research project because NerveSolutions has expressed an interest in licensing neuromodulation and stimulation technology from UTD that Dr. Romero created in collaboration with researchers from Draper Labs.
Neuromodulation of Individual Pelvic Floor Muscle Activity in Urinary Incontinence
Romero-Ortega+ Project Narrative Damage to pelvic floor muscles (PFM) often leads to alterations in their individual activity pattern, which is believed to contribute to some forms of urinary incontinence. This study aims to define the electrical stimulation pattern for individual PFM in micturition. It also proposes the use of miniature wireless neurotechnology for selective neuromodulation of the individual PFM as a strategy to re- establish their normal strength and activity patterns in multiparous and aging animals with urinary incontinence. This study will contribute to our understanding of the individual PFM in pelvic floor pathology, and evaluates the use of selective pelvic floor neuromodulation as a potential therapy for urinary incontinence. + + 1+
Filed on February 06, 2019.
Tell us what you know about Mario Romero's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.